CYTK - Cytokinetics, Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
31,033
31,501
13,368
106,407
28,658
Cost of Revenue
-
89,135
-
-
0
Gross Profit
-
-57,634
-
-
28,658
Operating Expenses
Research Development
91,068
89,135
90,296
59,897
46,398
Selling General and Administrative
36,584
31,282
36,468
27,823
19,667
Total Operating Expenses
127,652
120,417
126,764
87,720
66,065
Operating Income or Loss
-96,619
-88,916
-113,396
18,687
-37,407
Interest Expense
25,006
21,564
16,996
2,698
250
Total Other Income/Expenses Net
-
-
-
0
0
Income Before Tax
-117,520
-106,289
-127,790
16,453
-37,501
Income Tax Expense
-
-
-
0
0
Income from Continuing Operations
-117,520
-106,289
-127,790
16,453
-37,501
Net Income
-117,520
-106,289
-127,790
16,453
-37,501
Net Income available to common shareholders
-117,520
-106,289
-127,790
16,453
-37,501
Reported EPS
Basic
-
-1.95
-2.59
0.41
-0.97
Diluted
-
-1.95
-2.59
0.39
-0.97
Weighted average shares outstanding
Basic
-
54,420
49,404
39,943
38,814
Diluted
-
54,420
49,404
42,561
38,814
EBITDA
-
-83,486
-108,874
18,687
-37,407